Daridorexant for Alzheimer Disease Prevention

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study will evaluate whether daridorexant, a DORA sleep medication, can support brain health by promoting the clearance of proteins linked to the development and progression of Alzheimer\'s disease. The trial is preventive and is open to participants who do not have Alzheimer\'s disease dementia, regardless of whether or not they experience sleep problems.
Epistemonikos ID: d3e925aeb4cb403d6ea1acb12f6b7a961a52b408
First added on: Oct 09, 2025